German Center for Neurodegenerative Diseases (DZNE)
Philip Denner is currently the Head of Laboratory Automation Technologies at DZNE - German Center for Neurodegenerative Diseases since 2011. Previously, Philip worked as a Research Scientist in High Content Screening at Bayer AG from January 2007 to July 2010, focusing on the development of cellular assays to support preclinical drug development.
German Center for Neurodegenerative Diseases (DZNE)
The DZNE is a research institute that studies neurodegenerative diseases. Its mission is to understand the causes and risk factors that predispose to neurodegeneration and to develop new therapeutic and health care strategies. In order to promote high quality research in the field of neurodegeneration, the DZNE closely collaborates with its partner Universities. Like us on Facebook: www.facebook.com/dzne.de Follow us on Instagram: www.instagram.com/dzne_de Follow us on Twitter: @dzne_de / @dzne_en Imprint: www.dzne.de/imprint Data privacy: www.dzne.de/datenschutz